Medicare Enrolled
Dr. Sam Borno, MD
Interventional Cardiology · Fresno, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Borno from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borno?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Borno
Dr. Sam Borno is an interventional cardiology specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Borno performed 14,102 Medicare services across 10,651 unique beneficiaries.
Between the years covered by Open Payments, Dr. Borno received a total of $11,606 from 42 pharmaceutical and/or device companies across 474 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Borno is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in CA
$11,606 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,102
Medicare services
Top 4% in CA for interventional cardiology
10,651
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~705 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
2,360 | $44 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,118 | $91 | $140 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,910 | $10 | $60 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
1,324 | $37 | $48 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
1,012 | $146 | $700 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
693 | $58 | $250 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
677 | $367 | $1,000 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
657 | $146 | $330 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
644 | $68 | $100 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
407 | $56 | $300 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
394 | $710 | $1,200 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
393 | $19 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
299 | $68 | $180 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
243 | $55 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
116 | $118 | $230 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
106 | $42 | $190 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
106 | $20 | $180 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
106 | $186 | $450 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
80 | $69 | $95 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
78 | $7 | $20 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
74 | $20 | $50 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
54 | $77 | $150 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
49 | $17 | $60 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
37 | $48 | $85 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
37 | $59 | $130 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
37 | $21 | $50 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
28 | $21 | $60 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
27 | $35 | $50 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
23 | $27 | $100 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
13 | $35 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
42.6% medium
46.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,606
Total received (2018-2024)
Avg $1,658/year across 7 years
Top 37% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
474
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,606 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,529
2023
$2,089
2022
$1,727
2021
$771
2020
$1,049
2019
$2,199
2018
$2,242
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$555
Kestra Medical Technology Services, Inc.
$135
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$129
E.R. Squibb & Sons, L.L.C.
$120
Abbott Laboratories
$119
Merck Sharp & Dohme LLC
$90
Medtronic, Inc.
$89
PFIZER INC.
$56
Kiniksa Pharmaceuticals International, plc
$50
Alnylam Pharmaceuticals Inc.
$38
CVRx, Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Novartis Pharmaceuticals Corporation
$22
AstraZeneca Pharmaceuticals LP
$20
Janssen Pharmaceuticals, Inc
$19
Daiichi Sankyo Inc.
$17
Novo Nordisk Inc
$14
Top 3 companies account for 53.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,582
Boston Scientific Corporation
$1,277
Medtronic, Inc.
$594
BIOTRONIK INC.
$521
Janssen Pharmaceuticals, Inc
$491
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$483
Boehringer Ingelheim Pharmaceuticals, Inc.
$464
Abbott Laboratories
$426
PFIZER INC.
$414
Novartis Pharmaceuticals Corporation
$389
Medtronic Vascular, Inc.
$362
E.R. Squibb & Sons, L.L.C.
$319
Merck Sharp & Dohme LLC
$284
AstraZeneca Pharmaceuticals LP
$257
Akcea Therapeutics, Inc.
$210
Gilead Sciences, Inc.
$144
Kestra Medical Technology Services, Inc.
$135
ARALEZ PHARMACEUTICALS US INC.
$119
CVRx, Inc.
$111
Esperion Therapeutics, Inc.
$104
Astellas Pharma US Inc
$104
BOSTON SCIENTIFIC CORPORATION
$91
SANOFI-AVENTIS U.S. LLC
$90
Kiniksa Pharmaceuticals, Ltd.
$60
ARBOR PHARMACEUTICALS, INC.
$57
Novo Nordisk Inc
$51
Kiniksa Pharmaceuticals International, plc
$50
Lundbeck LLC
$49
Bayer HealthCare Pharmaceuticals Inc.
$41
Alnylam Pharmaceuticals Inc.
$38
Daiichi Sankyo Inc.
$38
Kowa Pharmaceuticals America, Inc.
$36
iRhythm Technologies, Inc.
$36
Arbor Pharmaceuticals, Inc.
$33
Edwards Lifesciences Corporation
$31
Regeneron Healthcare Solutions, Inc.
$20
Inspire Medical Systems, Inc.
$19
Baxter Healthcare
$17
Philips Electronics North America Corporation
$16
Lexicon Pharmaceuticals, Inc.
$16
SCPHARMACEUTICALS INC.
$15
Noden Pharma USA Inc
$12
Top 3 companies account for 47.0% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · ACCOLADE · AZURE XT DR MRI SURESCAN · Arcalyst · Assure WCD · Azure · BELSOMRA · BRILINTA · Barostim Neo System · CAMZYOS · CHANTIX · COBALT DR MRI SURESCAN · COROFLOW · CardioMEMS HF System · Claria MRI · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FUROSCIX · GENERAL BRADY · GENERAL BRADY · General - Brady · Hillrom - Carnation Ambulatory Monitor · INJECTAFER · INSPIRE · Inpefa · JARDIANCE · LATITUDE · LEQVIO · LEXISCAN · LUX-DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MERLIN@HOME · MICRA · MITRACLIP · Mitra Clip system · NEXLETOL · NORTHERA · ONPATTRO · ONYX FRONTIER · PRADAXA · PRALUENT · Pacemakers · Repatha · Reveal LINQ · TEGSEDI · TEKTURNA · VERQUVO · VYNDAQEL · Verquvo · WATCHMAN · XARELTO · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
7
Per 100K population
0.7
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Borno is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Borno experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Borno performed 2,360 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borno receive payments from pharmaceutical companies?
Yes. Dr. Borno received a total of $11,606 from 42 companies across 474 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borno's costs compare to other interventional cardiologists in Fresno?
Dr. Borno's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borno) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Fresno
Browse interventional cardiologists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology